SoluBest and Dr Reddy’s ink formulation development deal
SoluBest and Dr Reddy’s Laboratories are joining forces to develop a proprietary formulation of one of SoluBest’s pipeline compounds using its Solumer platform.
SoluBest and Dr Reddy’s Laboratories are joining forces to develop a proprietary formulation of one of SoluBest’s pipeline compounds using its Solumer platform.
Halozyme Therapeutics will cut its workforce 25 per cent to focus on strategic alliances and development of most advanced in-house candidates.